JPS6353993B2 - - Google Patents

Info

Publication number
JPS6353993B2
JPS6353993B2 JP20066981A JP20066981A JPS6353993B2 JP S6353993 B2 JPS6353993 B2 JP S6353993B2 JP 20066981 A JP20066981 A JP 20066981A JP 20066981 A JP20066981 A JP 20066981A JP S6353993 B2 JPS6353993 B2 JP S6353993B2
Authority
JP
Japan
Prior art keywords
glu
acetone
hhdp
gal
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP20066981A
Other languages
Japanese (ja)
Other versions
JPS58103383A (en
Inventor
Itsuo Nishioka
Genichiro Nonaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shinyaku Co Ltd
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Priority to JP20066981A priority Critical patent/JPS58103383A/en
Publication of JPS58103383A publication Critical patent/JPS58103383A/en
Publication of JPS6353993B2 publication Critical patent/JPS6353993B2/ja
Granted legal-status Critical Current

Links

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は医薬品として有用な新規タンニンに関
する。 タンニンは広く植物界に分布し、収斂作用のあ
ることが古くから知られ、収斂薬として、また皮
を革に変化させるなめし剤として多く用いられて
きた。 タンニンは分子量600〜2000ほどの植物の微量
成分で複雑な構造を有しており、単離精製の困難
さあいまつて研究が遅れていた。 一方、従来より、地楡等の植物が、酵素阻害作
用等に基づく有用な医薬的効果を有することが知
られていた。 本発明者らは、これらの植物の薬効成分を検索
する目的でこれらに含まれる成分を単離取得して
薬理効果を調べた結果、幸運にも新規なるタンニ
ンに酵素阻害作用のあることを見出し本発明を完
成した。 本発明に係る化合物は、体中酵素蛋白と結合す
ることによつてその活性を低下させる作用を有し
ている。 本発明に係る化合物は、地楡、ウラジロガシ、
桂皮、キナ皮、メヒルギ、栗樹皮等の植物から、
アセトンによる抽出、酢酸エチル:水の分配、あ
るいはカラムクロマト等の公知の方法により容易
に得ることができる。 以下に本発明化合物の取得方法の実施例を掲げ
て本発明の詳細に説明する。 実施例 1 ウラジロガシ皮6.3Kgを60%の水性アセトン5
で抽出し、アセトンを留去後、析出する沈澱を
濾去する。濾液を酢酸エチル1で10回分配し、
酢酸エチル可溶部をあつめ、Sephadex LH−20
でエタノールを用いカラムクロマトグラフイー分
離を行い、6個のフラクシヨンに分画する。フラ
クシヨン1を更にSephadex LH−20でアセトン
を用いてカラムクロマトグラフイー分離を行い、
ついでピリジン−水の混液から再結晶を行い1.2
gの黄色結晶を得た。 1(β)−galloyl pedunculagin (収率0.006
%)無色無定形粉末〔α〕D+35.2゜(acetone、c=
1.08) PMR(acetone−d6)ppm:3.87(1H、br.d、J=
14Hz、glu.C6−H)、4.48(1H、dd、J=8.6Hz、
glu.C5−H)、5.13(1H、t、J=9Hz、glu.C4
−H)、5.13(1H、t、J=8Hz、glu.C2−H)、
5.47(1H、t、J=8Hz、glu.C3−H)、5.12−
5.52(glu.C6−H)、6.22(1H、d、J=8Hz、
anom.H)、6.38、6.47、6.55、6.68(each 1H、
s、HHDP.H)、7.18(2H、s、gal.H). CMR(acetone−d6+D2O)ppm:62.3(glu.C6)、
69.0(glu.C4)、73.2(glu.C2)、75.7(glu.C3)、
77.0(glu.C5)、91.3(glu.C1)、106.8、107.0、
107.9(HHDP、C5、C5′)、110.0(gal.C2、C6)、
114.1、114.7、115.5、115.8(HHDP.C1、C1′)、
119.1(gal.C1)、125.2、125.4、125.7(HHDP.
C6、C6′)、135.9、136.2(HHDP.C3、C3′)、
139.7(gal.C4)、144.1、144.8、144.9、145.8
(HHDP、C2、C2′、C4、C4′、gal.C3、C5)、
164.9、167.7、168.0、168.4、169.1(−COO−). ただし、Gはガロイル基
The present invention relates to novel tannins useful as pharmaceuticals. Tannins are widely distributed in the plant kingdom, and have long been known to have astringent effects, and have been widely used as an astringent and as a tanning agent to transform hides into leather. Tannin is a trace component of plants with a molecular weight of 600 to 2,000 and has a complex structure, and research on it has been delayed due to difficulties in isolating and purifying it. On the other hand, it has been conventionally known that plants such as elms have useful medicinal effects based on enzyme inhibitory effects and the like. The present inventors isolated and obtained the components contained in these plants for the purpose of searching for medicinal components and examined their pharmacological effects. Fortunately, the inventors discovered that a new tannin has an enzyme-inhibiting effect. The invention has been completed. The compound according to the present invention has the effect of reducing the activity of enzyme proteins in the body by binding to them. The compound according to the present invention includes elm, elm,
From plants such as cinnamon bark, cinchona bark, cane bark, chestnut bark, etc.
It can be easily obtained by known methods such as extraction with acetone, ethyl acetate:water partitioning, or column chromatography. The present invention will be described in detail below with reference to Examples of methods for obtaining the compounds of the present invention. Example 1 6.3 kg of horseradish skin was mixed with 60% aqueous acetone 5
After the acetone is distilled off, the precipitate is filtered off. The filtrate was partitioned 10 times with 1 part of ethyl acetate,
Collect the ethyl acetate soluble portion and store it in Sephadex LH-20.
Column chromatography separation using ethanol is performed to separate into 6 fractions. Fraction 1 was further separated by column chromatography using acetone on Sephadex LH-20.
Then recrystallize from a pyridine-water mixture 1.2
g yellow crystals were obtained. 1(β)-galloyl pedunculagin (yield 0.006
%) Colorless amorphous powder [α] D +35.2゜(acetone, c=
1.08) PMR (acetone-d 6 ) ppm: 3.87 (1H, br.d, J=
14Hz, glu.C 6 −H), 4.48 (1H, dd, J=8.6Hz,
glu.C 5 −H), 5.13 (1H, t, J=9Hz, glu.C 4
-H), 5.13 (1H, t, J=8Hz, glu.C 2 -H),
5.47 (1H, t, J=8Hz, glu.C 3 −H), 5.12−
5.52 (glu.C 6 −H), 6.22 (1H, d, J = 8Hz,
anom.H), 6.38, 6.47, 6.55, 6.68 (each 1H,
s, HHDP.H), 7.18 (2H, s, gal.H). CMR (acetone−d 6 + D 2 O) ppm: 62.3 (glu.C 6 ),
69.0 (glu.C 4 ), 73.2 (glu.C 2 ), 75.7 (glu.C 3 ),
77.0 (glu.C 5 ), 91.3 (glu.C 1 ), 106.8, 107.0,
107.9 (HHDP, C 5 , C 5 ′), 110.0 (gal.C 2 , C 6 ),
114.1, 114.7, 115.5, 115.8 (HHDP.C 1 , C 1 ′),
119.1 (gal.C 1 ), 125.2, 125.4, 125.7 (HHDP.
C 6 , C 6 ′), 135.9, 136.2 (HHDP.C 3 , C 3 ′),
139.7 (gal.C 4 ), 144.1, 144.8, 144.9, 145.8
(HHDP, C 2 , C 2 ′, C 4 , C 4 ′, gal.C 3 , C 5 ),
164.9, 167.7, 168.0, 168.4, 169.1 (−COO−). However, G is galloyl group

【式】を表す。Represents [formula].

Claims (1)

【特許請求の範囲】 1 次の式〔〕 で表される化合物。ただし、Gはガロイル基
【式】を表す。
[Claims] 1. The following formula [] A compound represented by However, G represents a galloyl group [Formula].
JP20066981A 1981-12-12 1981-12-12 New tannin Granted JPS58103383A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP20066981A JPS58103383A (en) 1981-12-12 1981-12-12 New tannin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20066981A JPS58103383A (en) 1981-12-12 1981-12-12 New tannin

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP20080186A Division JPH0231074B2 (en) 1986-08-26 1986-08-26 SHINTANNIN

Publications (2)

Publication Number Publication Date
JPS58103383A JPS58103383A (en) 1983-06-20
JPS6353993B2 true JPS6353993B2 (en) 1988-10-26

Family

ID=16428259

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20066981A Granted JPS58103383A (en) 1981-12-12 1981-12-12 New tannin

Country Status (1)

Country Link
JP (1) JPS58103383A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH657866A5 (en) * 1983-07-06 1986-09-30 Nestle Sa ANTIOXYGEN PROTECTION OF FOOD AND COSMETIC PRODUCTS BY PLANT EXTRACTS.
JPS6116982A (en) * 1984-07-03 1986-01-24 Kikkoman Corp Antioxidant
SG188529A1 (en) * 2010-09-14 2013-04-30 Chengdu Keer Pharmaceutical Co Ltd A sanguisorba tannin extract, and preparation method and use thereof

Also Published As

Publication number Publication date
JPS58103383A (en) 1983-06-20

Similar Documents

Publication Publication Date Title
US4108985A (en) Dihydrocyclosporin c
US4210581A (en) Organic compounds
Sanger The free amino group of gramicidin S
JPS6222990B2 (en)
JPH0229078B2 (en)
Rao et al. E-73: An antitumor substance. Part I. isolation and characterization1
EP0036663A1 (en) Oxiranebutanoic acid derivatives, their preparation and use, and medicaments containing them
NO863329L (en) PHARMACOLOGICAL EFFECT.
SU980627A3 (en) Process for producing n-desmethylvinblastine, vincristine, n-desmethylleurosine, h-dimethyl-n-formylleurosine, n-dismethyl-n-(ethoxymethyl)-vinblastine, n-desmethyl-n-(ethoxymethyl)-leurosine or their salts
JPS62142181A (en) Novel tannin
McKay et al. Amino Acids. II. Synthesis of Cyclic Guanidino Acids1
JPH0231074B2 (en) SHINTANNIN
JPS6353993B2 (en)
JPH0246598B2 (en) SHINKINARUTANNIN
JPS6249279B2 (en)
JP2506687B2 (en) Caffeine excitatory inhibitor
CA1320952C (en) Antitumor alkaloids
Boger et al. Thermal, three-carbon+ two-atom cycloaddition of cyclopropenone ketals with carbon-heteroatom double bonds: Butenolide, furan, and γ-keto ester preparation.
JPH0160475B2 (en)
JPS6136826B2 (en)
JPS6317079B2 (en)
Kupchan et al. Zygadenus Alkaloids. VI. 1 Active Principles of Zygadenus paniculatus2
JPH0225909B2 (en)
JPS6249278B2 (en)
JPS61112089A (en) Novel tannin